CSF1 and breast carcinoma: To determine if the activity of the enhancer might be contributing to the increased CSF1 expression in TNBC tumors, we analyzed The Cancer Genome Atlas (TCGA) ATAC-seq data to compare the chromatin accessibility landscape of this enhancer across 133 breast cancer samples [89].